For purposes of this chapter, the following terms have the following definitions:

1. (a) “DEHP” means Di(2-ethylhexyl) phthalate.
2. (b) “Intentionally added DEHP” means DEHP that a manufacturer has intentionally added to an intravenous solution container or intravenous tubing product that has a functional or technical effect on the product.
3. (c) “Intravenous solution containers” means a container used to house medicine, fluid, or nutrition therapy that is intravenously administered to patients in a hospital, outpatient, or other health care facility.
4. (d) “Intravenous tubing” means any tubing used to intravenously administer fluids, medication, or nutrients directly to an adult, child, or infant.

5. (e) “Ortho-phthalates” means a class of chemicals that are esters of ortho-phthalic acid, including all of the following:

   1. (1) Benzyl-butyl phthalate (BBP) 85-68-7.
   2. (2) Dibutyl phthalate (DBP) 84-74-2.
   3. (3) Dicyclohexyl phthalate (DCHP) 84-61-7.
   4. (4) Di-(2-ethylhexyl) phthalate (DEHP) 117-81-7.
   5. (5) Diethyl phthalate (DEP) 84-66-2.
   6. (6) Di-isobutyl phthalate (DIBP) 84-69-5.
   7. (7) Di-isodecyl phthalate (DIDP) 26761-40-0.
   8. (8) Di-isononyl phthalate (DINP) 28553-12-0.
   9. (9) Di-n-hexyl phthalate (DnHP) 84-75-3.
   10. (10) Di-n-octyl phthalate (DNOP) 117-84-0.
   11. (11) Di-n-pentyl (DnPP) phthalate 131-18-0.
   12. (12) Diisoheptyl phthalate (DIHP) 71888-89-6.
6. (f) “Unintentionally added DEHP” means DEHP in an intravenous solution container or intravenous tubing product that is not used for functional or technical effect on the product.